Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

The Adrenal Receptor for Angiotensin II is Altered in Essential Hypertension
Gordon H. Williams, … , Stephen L. Swartz, Robert G. Dluhy
Gordon H. Williams, … , Stephen L. Swartz, Robert G. Dluhy
Published March 1, 1979
Citation Information: J Clin Invest. 1979;63(3):419-427. https://doi.org/10.1172/JCI109318.
View: Text | PDF
Research Article

The Adrenal Receptor for Angiotensin II is Altered in Essential Hypertension

  • Text
  • PDF
Abstract

To determine the mechanism underlying altered adrenal responsiveness in patients with essential hypertension, the renin-angiotensin-aldosterone axis was assessed in normotensive and hypertensive subjects using three pharmacological probes: SQ 20881, a converting enzyme inhibitor; saralasin, a competitive angiotensin antagonist with prominent agonist properties; and angiotensin itself. All subjects were studied while supine and in balance on a 10 meq Na/100 meq K intake. The decrement in plasma aldosterone with SQ 20881 in 26 hypertensive subjects (15±3 ng/dl) was normal (13±4 ng/dl), suggesting that the altered adrenal responsiveness in hypertensives is not because of a change in a postreceptor event or in the relative contribution of angiotensin to the control of aldosterone secretion.

Authors

Gordon H. Williams, Norman K. Hollenberg, Thomas J. Moore, Stephen L. Swartz, Robert G. Dluhy

×

Total citations by year

Year: 1993 1991 1983 1982 1981 1979 Total
Citations: 1 1 2 4 2 1 11
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (11)

Title and authors Publication Year
Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers
MR Goldberg, W Tanaka, A Barchowsky, TE Bradstreet, J McCrea, MW Lo, EJ McWilliams, TD Bjornsson
Hypertension 1993
Feasibility of outpatient electrolyte balance studies
ML McCullough, JF Swain, C Malarick, TJ Moore
Journal of the American College of Nutrition 1991
Achievements in hypertension: A 25 year overview
ED Frohlich
Journal of the American College of Cardiology 1983
Nervous disorders of renal function
AD Baines
Clinical Biochemistry 1983
Decreased adrenal responsiveness to angiotensin II: a defect present in spontaneously hypertensive rats. A possible model of human essential hypertension
GH Williams, LM Braley, A Menachery
Journal of Clinical Investigation 1982
Rapid increase of mineralocorticoids after furosemide in low-renin essential hypertension: Evidence for 18-hydroxycorticosterone to be a better marker than aldosterone
H Witzgall, G Thayil, PC Weber
Klinische Wochenschrift 1982
Parallel adrenal and renal abnormalities in young patients with essential hypertension
GH Williams, ML Tuck, JM Sullivan, RG Dluhy, NK Hollenberg
The American Journal of Medicine 1982
Dopaminergic modulation of pressor and hormonal responses in essential hypertension
JR Sowers, MS Golub, ME Berger, LA Whitfield
Hypertension 1982
Response of aldosterone and 18-hydroxycorticosterone to angiotensin II in normal subjects and patients with essential hypertension, Conn's syndrome, and nontumorous hyperaldosteronism
R Fraser, C Beretta-Piccoli, JJ Brown, AM Cumming, AF Lever, PA Mason, JJ Morton, JI Robertson
Hypertension 1981
Contemporary Nephrology
S Klahr, SG Massry
1981
Abnormal Adrenal Responsiveness and Angiotensin II Dependency in High Renin Essential Hypertension
RG Dluhy, SZ Bavli, FK Leung, HS Solomon, TJ Moore, NK Hollenberg, GH Williams
Journal of Clinical Investigation 1979

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts